Related references
Note: Only part of the references are listed.The global aHUS registry: methodology and initial patient characteristics
Christoph Licht et al.
BMC NEPHROLOGY (2015)
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry
Hubert Schrezenmeier et al.
HAEMATOLOGICA (2014)
Why do we continue to adopt medical practices based on pathophysiology alone when we should be insisting on clinical trials?
Vinay Prasad et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Chronic Histological Damage in Early Indication Biopsies Is an Independent Risk Factor for Late Renal Allograft Failure
M. Naesens et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Does Expanded Criteria Donor Status Modify the Outcomes of Kidney Transplantation From Donors After Cardiac Death?
S. K. Singh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes
G. Canaud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Nontuberculous Mycobacterial Infections in Solid Organ Transplantation
M. R. Keating et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy
Regis Peffault de Latour et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Humoral theory of transplantation: some hot topics
Junchao Cai et al.
BRITISH MEDICAL BULLETIN (2013)
Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults
Veronique Fremeaux-Bacchi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The use of eculizumab in renal transplantation
A. Nicholas R. Barnett et al.
CLINICAL TRANSPLANTATION (2013)
Renal allograft pathology in the sensitized patient
Lynn D. Cornell
CURRENT OPINION IN ORGAN TRANSPLANTATION (2013)
Very long-term survivors of kidney transplantation
Carol Traynor et al.
TRANSPLANT INTERNATIONAL (2013)
Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports
B. Kocak et al.
TRANSPLANTATION PROCEEDINGS (2013)
Eculizumab in renal transplantation
Christophe Legendre et al.
TRANSPLANTATION REVIEWS (2013)
Recurrent Dense Deposit Disease After Renal Transplantation: An Emerging Role for Complementary Therapies
J. A. McCaughan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Multiple Hyperacute Rejections in the Absence of Detectable Complement Activation in a Patient With Endothelial Cell Reactive Antibody
A. M. Jackson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Monitoring the Safety of Medicines Used Off-Label
G. J. Dal Pan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
New immunosuppressants in pediatric solid organ transplantation
Stephen D. Marks
CURRENT OPINION IN ORGAN TRANSPLANTATION (2012)
Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab
Kyle L. Dawson et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
The role of complement in antibody-mediated rejection in kidney transplantation
Mark D. Stegall et al.
NATURE REVIEWS NEPHROLOGY (2012)
The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs
Aaron S. Kesselheim et al.
PLOS ONE (2012)
Protein S deficiency in a living liver donor
William H. Kitchens et al.
TRANSPLANT INTERNATIONAL (2012)
Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale
Thomas Fehr et al.
TRANSPLANT INTERNATIONAL (2012)
Eculizumab Treatment of Acute Antibody-Mediated Rejection in Renal Transplantation: Case Reports
F. Gonzalez-Roncero et al.
TRANSPLANTATION PROCEEDINGS (2012)
Case Report: Eculizumab Rescue of Severe Accelerated Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplant
Z. A. Stewart et al.
TRANSPLANTATION PROCEEDINGS (2012)
Recent Developments in Desensitization of Crossmatch-positive Kidney Transplant Recipients
C. Morath et al.
TRANSPLANTATION PROCEEDINGS (2012)
Chronic renal allograft injury: early detection, accurate diagnosis and management
Julio Pascual et al.
TRANSPLANTATION REVIEWS (2012)
Eculizumab in Acute Recurrence of Thrombotic Microangiopathy After Renal Transplantation
K. Hadaya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
M. D. Stegall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Desensitization Protocols and Their Outcome
Kwaku Marfo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Modifiers of complement activation for prevention of antibody-mediated injury to allografts
Peter D. Hughes et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2011)
Antibody-mediated rejection in kidney transplantation: an update
Jessica G. Lucas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Use of monoclonal antibodies in renal transplantation
Martijn W. F. van den Hoogen et al.
IMMUNOTHERAPY (2011)
Reversal of refractory antibody-mediated rejection in blood group incompatible kidney transplantation by Eculizumab
C. Morath et al.
MOLECULAR IMMUNOLOGY (2011)
Eculizumab and renal transplantation in a patient with catastrophic antiphospholipid syndrome: effect of heparin on complement activation
C. Velik-Salchner et al.
LUPUS (2011)
THERAPY Off-label biologics use and infection risk-the great unknown
Kevin L. Winthrop et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Perspectives in pediatric renal transplantation
Gwenaelle Roussey-Kesler et al.
NEPHROLOGIE & THERAPEUTIQUE (2011)
Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation
Ali-Reza Biglarnia et al.
TRANSPLANT INTERNATIONAL (2011)
Successful Treatment of De Novo Posttransplant Thrombotic Microangiopathy With Eculizumab
Colin H. Wilson et al.
TRANSPLANTATION (2011)
Eculizumab for the Treatment of De Novo Thrombotic Microangiopathy Post Simultaneous Pancreas-Kidney Transplantation-A Case Report
S. Chandran et al.
TRANSPLANTATION PROCEEDINGS (2011)
Thrombotic Microangiopathy After Kidney Transplantation
M. Noris et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Eculizumab, Bortezomib and Kidney Paired Donation Facilitate Transplantation of a Highly Sensitized Patient Without Vascular Access
B. E. Lonze et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Deciphering antibody-mediated rejection: new insights into mechanisms and treatment
Mark D. Stegall et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2010)
Advances in immunosuppression for renal transplantation
Antoine Durrbach et al.
NATURE REVIEWS NEPHROLOGY (2010)
Eculizumab and Renal Transplantation in a Patient with CAPS.
Bonnie E. Lonze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Advances in diagnosing and managing antibody-mediated rejection
Stanley C. Jordan et al.
PEDIATRIC NEPHROLOGY (2010)
The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody-Mediated Rejection
J. E. Locke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Controlling Off-Label Medication Use
Muriel R. Gillick
ANNALS OF INTERNAL MEDICINE (2009)
Case reports and case series from Lancet had significant impact on medical literature
J Albrecht et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
Share Paper
